The US tissue diagnostics market is anticipated to grow at a CAGR 6.9% during the forecast period. The US is dominating the tissue diagnostic market in terms of revenue and R&D. Government and private ventures are contributing significantly to the growth of the US tissue diagnostic market. The implementation of the Affordable Care Act boosted the healthcare system of U.S. New insurance policies and reforms in the healthcare system are expected to create significant opportunities for the tissue diagnostic market. The healthcare spending is highest in the US which is estimated to be $8,608 per person. Tissue diagnostics market is triggered by the significant demand for diagnosis and treatment for cancer and related diseases. According to the American Institute of Cancer, Research Cancer is considered to be a menace that is responsible for 300 fatalities in every 0.1 million cases. The diagnosis cost, tests, stain and other diagnostic devices are highest in the U.S. compared to other regions.

Request a Free Report on Sample of US Tissue Diagnostics Market https://www.omrglobal.com/request-sample/us-tissue-diagnostics-market

Most of the key players are based in the US contributing to the growth of the tissue diagnostics market through mergers and acquisitions, partnerships and collaboration. For instance, Danaher is expected to acquire Cepheid at $ 4 billion which is a molecular diagnostics company that develops manufactures and markets molecular systems and tests in the US. Procedure volume growth is significantly high in the US due to the huge prevalence of cancer patients, improving healthcare infrastructure, improved insurance coverage and reimbursement policies. The other key factors that are driving the US market of tissue diagnostics market include reforms in the healthcare sector, rising awareness for tissue diagnostics and adoption of personalized medicines among others. Major players those are active in the market that includes Abbott Laboratories, Inc., Agilent Technologies, Biogenex Laboratories, Cell Signaling Technology, Inc., Bio SB, Danaher Corporation, Life Technologies, Thermo Fisher Scientific, Inc and Sigma-Aldrich.

A full Report of US Tissue Diagnostics Market is Available at: https://www.omrglobal.com/industry-reports/us-tissue-diagnostics-market

US Tissue Diagnostics Market Segmentation

By Technology

• Immunohistochemistry
• In Situ Hybridization
• Digital Pathology And Workflow Management
• Special Staining
• Hematoxylin & Eosin (H&E) Stain

By Diseases

• Breast Cancer
• Gastric Cancer
• Lymphoma
• Prostate Cancer
• Non-small Cell Lung Carcinoma

By Product

• Instruments
• Consumables

By End-User

• Hospitals
• Pharmaceuticals
• Research Institute
• Laboratories
• Other Research



Company Profiles

• Alere, Inc.
• Becton, Dickinson and Co.,
• Bio SB
• Biogenex Laboratories
• BioMérieux SA
• Cell Signalling Technology, INC.
• DiaGenic ASA
• Prometheus Laboratories
• QIAGEN AG
• Stryker Corp.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/us-tissue-diagnostics-market

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit https://www.omrglobal.com

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +1 646-755-7667, +91 780-304-0404